148 related articles for article (PubMed ID: 8082240)
21. [Differential immunohistochemical diagnosis of tumors of the human central nervous system using monoclonal antibodies].
Vial'tseva IuIu; Bukhvalov IB; Vasilov RG
Arkh Patol; 1996; 58(2):28-32. PubMed ID: 8712936
[TBL] [Abstract][Full Text] [Related]
22. [Importance of immunohistochemistry for neuro-oncology. III. Demonstration of glial fibrillary acidic proteins (GFAP) in anaplastic astrocytomas and glioblastomas].
Martin H; Gottschalk J; Hufnagl P; Szymaś J
Zentralbl Allg Pathol; 1986; 132(3):209-14. PubMed ID: 3538706
[TBL] [Abstract][Full Text] [Related]
23. Ultrastructural immunocytochemistry in glial tumors.
Migheli A; Mocellini C
J Neurosurg Sci; 1990; 34(3-4):219-22. PubMed ID: 2129126
[TBL] [Abstract][Full Text] [Related]
24. Glial fibrillary acidic protein and its fragments discriminate astrocytoma from oligodendroglioma.
Luider TM; Kros JM; Sillevis Smitt PA; van den Bent MJ; Vecht CJ
Electrophoresis; 1999; 20(4-5):1087-91. PubMed ID: 10344289
[TBL] [Abstract][Full Text] [Related]
25. Intermediate filaments and anaplastic change of ENU-induced gliomass: immunohistochemical study with vimentin and astroprotein (GFAP).
Yoshimine T; Maruno M; Ushio Y; Hayakawa T; Nakajima Y; Mogami H
J Neurooncol; 1987; 5(4):377-85. PubMed ID: 3440878
[TBL] [Abstract][Full Text] [Related]
26. Effects of mycophenolic acid on detection of glial filaments in human and rat astrocytoma cultures.
Lipsky RH; Silverman SJ
Cancer Res; 1987 Sep; 47(18):4900-4. PubMed ID: 3304619
[TBL] [Abstract][Full Text] [Related]
27. [Immunohistochemical study of ethylnitrosourea-induced rat gliomas with vimentin and astroprotein (GFAP)].
Maruno M; Yoshimine T; Ushio Y; Hayakawa T; Jamshid J; Bitoh S; Mogami H
No To Shinkei; 1985 Dec; 37(12):1173-9. PubMed ID: 4091986
[TBL] [Abstract][Full Text] [Related]
28. [Significance of immunohistochemistry in neuro-oncology. I. Demonstration of glial fibrillary acid protein (GFAP) in extracranial metastases from primary brain tumors].
Gottschalk J; Martin H; Kretschmer B; Barz H; Janda J; Szymas J
Zentralbl Allg Pathol; 1985; 130(5):391-6. PubMed ID: 3913231
[TBL] [Abstract][Full Text] [Related]
29. Expression of glial fibrillary acidic protein, vimentin, fibronectin, and N-myc oncoprotein in primary human brain tumor cell explants.
Mapstone TB; Galloway PG
Pediatr Neurosurg; 1991-1992; 17(4):169-74. PubMed ID: 1668298
[TBL] [Abstract][Full Text] [Related]
30. Characterization of glial filament-cytoskeletal interactions in human astrocytomas: an immuno-ultrastructural analysis.
Rutka JT; Ackerley C; Hubbard SL; Tilup A; Dirks PB; Jung S; Ivanchuk S; Kurimoto M; Tsugu A; Becker LE
Eur J Cell Biol; 1998 Aug; 76(4):279-87. PubMed ID: 9765058
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological study of cellular proliferation and invasion in gliomatosis cerebri: important role of neural cell adhesion molecule L1 in tumour invasion.
Suzuki T; Izumoto S; Fujimoto Y; Maruno M; Ito Y; Yoshimine T
J Clin Pathol; 2005 Feb; 58(2):166-71. PubMed ID: 15677537
[TBL] [Abstract][Full Text] [Related]
32. Aberrant localization of the neuronal class III beta-tubulin in astrocytomas.
Katsetos CD; Del Valle L; Geddes JF; Assimakopoulou M; Legido A; Boyd JC; Balin B; Parikh NA; Maraziotis T; de Chadarevian JP; Varakis JN; Matsas R; Spano A; Frankfurter A; Herman MM; Khalili K
Arch Pathol Lab Med; 2001 May; 125(5):613-24. PubMed ID: 11300931
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
[TBL] [Abstract][Full Text] [Related]
34. Proteins of the intermediate filament cytoskeleton as markers for astrocytes and human astrocytomas.
Yang HY; Lieska N; Shao D; Kriho V; Pappas GD
Mol Chem Neuropathol; 1994; 21(2-3):155-76. PubMed ID: 7522006
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of S100 calcium-binding proteins characterizes distinct clinical entities in both WHO grade II and III astrocytic tumours.
Camby I; Lefranc F; Titeca G; Neuci S; Fastrez M; Dedecken L; Schäfer BW; Brotchi J; Heizmann CW; Pochet R; Salmon I; Kiss R; Decaestecker C
Neuropathol Appl Neurobiol; 2000 Feb; 26(1):76-90. PubMed ID: 10736069
[TBL] [Abstract][Full Text] [Related]
36. Identification of gliomas by morphological and immunocytochemical analysis in cell cultures.
Fazekas I; Kerekes E; Hegedús B; Nyáry I
Ideggyogy Sz; 2002 May; 55(5-6):173-9. PubMed ID: 12122877
[TBL] [Abstract][Full Text] [Related]
37. Vimentin and glial fibrillary acidic protein in human brain tumors.
Yung WK; Luna M; Borit A
J Neurooncol; 1985; 3(1):35-8. PubMed ID: 3889231
[TBL] [Abstract][Full Text] [Related]
38. [Glial fibrillary acidic protein and central nervous tumors. Immunohistochemical study of a series of 207 cases. 1: Astrocytomas. Glioblastomas. Ependymomas. Papillomas of the choroid plexus].
Pasquier B; Lachard A; Pasquier D; Couderc P; Delpech B; Courel MN
Ann Pathol; 1983; 3(2):127-35. PubMed ID: 6307324
[TBL] [Abstract][Full Text] [Related]
39. Expression of non-glial intermediate filament proteins in gliomas.
Hirato J; Nakazato Y; Ogawa A
Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
[TBL] [Abstract][Full Text] [Related]
40. [Clinicopathological study on malignant glioma--with special reference to GFAP].
Tajika T; Kubo O; Tajika Y; Toyama T; Himuro H; Inoue N; Sakairi M; Kitamura K
No Shinkei Geka; 1986 Jun; 14(7):831-5. PubMed ID: 3020463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
